A Randomized Controlled Trial of Late Conversion From Calcineurin Inhibitor (CNI)-Based to Sirolimus-Based Immunosuppression in Liver Transplant Recipients with Impaired Renal Function
Open accessThe DOI matches its Crossref record.
Abstract
Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a single-center, randomized, controlled trial, 30 patients at least 6 months post liver transplantation were randomized to remain on CNI-based immunosuppression or to switch to sirolimus-based immunosuppression. The primary outcome measure was change in measured glomerular filtration rate (GFR) between baseline and 12 months. Of 30 patients randomized, 3 were withdrawn at randomization, leaving 14 patients on CNI and 13 on sirolimus. There was a significant improvement in delta GFR following conversion to sirolimus at 3 months (7.7 mL/minute/1.73 m 2 ; 95% confidence interval, 3.5–11.9) and 1 yr (6.1 mL/minute/1.73 m 2 ; 95% confidence interval, 0.9–11.4). The difference in absolute GFR between the 2 study groups was significant at 3 months ( P = 0.02), but not at 12 months ( P = 0.07). The principal adverse events following conversion were the development of skin rash (9 of 13 patients, 69%) and mouth ulcers (5 of 13 patients, 38%). Two patients developed acute rejection at 2 and 3 months following conversion, 1 in association with low sirolimus levels and 1 having stopped the drug inadvertently. In conclusion, overall, this study suggests that conversion to sirolimus immunosuppression is associated with a modest improvement in renal function. Side effects were common, but tolerable in most patients and controlled with dose reduction. Liver Transpl 13:1694–1702, 2007. © 2007 AASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544
Liver transplantation: Current status and challenges
Jadlowiec, C. C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i18.4438 · Cited by 302
A comprehensive review of immunosuppression used for liver transplantation
Mukherjee, S., & Mukherjee, U. (2009) · Journal of Transplantation · doi:10.1155/2009/701464 · Cited by 140
Nelson, J., Alvey, N., Bowman, L., Schulte, J., Segovia, M. C., McDermott, J., Te, H. S., Kapila, N., Levine, D. J., Gottlieb, R. L., et al. (2022) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2716 · Cited by 130
Immunosuppression minimization vs. complete drug withdrawal in liver transplantation
Londoño, M.-C., Rimola, A., O’Grady, J., & Sanchez-Fueyo, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.003 · Cited by 118
“Results ranged from no benefit [32–34] to mild increases in glomerular filtration rate [33–35].”
BackgroundCardiovascular disease outcomes related to early stage renal impairment after liver transplantation
VanWagner, L. B., Montag, S., Zhao, L., Allen, N. B., Lloyd-Jones, D. M., Das, A., Skaro, A. I., Hohmann, S., Friedewald, J. J., & Levitsky, J. (2018) · Transplantation · doi:10.1097/tp.0000000000002175 · Cited by 32
Metadata
- Authors
- Watson, C. J. E., Gimson, A. E. S., Alexander, G. J., Allison, M. E. D., Gibbs, P., Smith, J. C., Palmer, C. R., & Bradley, A. J.
- Venue
- Liver Transplantation
- Published
- 2007-12
- Volume
- 13
- Issue
- 12
- Pages
- 1694-1702
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2057830383
- Cited by
- 98
- References
- 0
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.